CKD sales of Dilatrend and Simvalord on ever growing.
Published: 2006-05-04 06:59:00
Updated: 2006-05-04 06:59:00
The sales of Chongkundang's major cardiovascular drugs, Dilatrend and Simvalord, reported a remarkable growth every year. The sales trend of Dilatrend showed 50,494 MW in 2005, 15,000 MW more than 36,850 MW of 2004 and 28,397 MW of 2003.
Simvalord sales also rose 10,988 MW in 2005, which was ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
